top of page
New Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment in CLL
Thu, Nov 12
|Webinar
Registration is Closed
See other events
Time & Location
Nov 12, 2020, 9:00 PM
Webinar
About The Event
Thursday, November 12, 2020, 9:00 PM ET
Harry Erba, MD, PhD Professor, Department of Medicine, Director of the Leukemia Program and Director of Phase I Development in Hematologic Malignancies, Duke University, Durham, NC
Nakhle Saba, MD Associate Professor of Medicine, Section of Hematology and Medical Oncology Tulane University, New Orleans, LA
REGISTER via link below
https:// abbvie.meintl.com/00071-OB21-20
DURING THIS INTERACTIVE PROGRAM WE WILL:
bottom of page